← Back to All Filings

Goldman Sachs Amends Stake in Definitive Healthcare (DH) to 5.7%

High SignificanceFebruary 9, 2026 at 4:12:49 PM EST

Definitive Healthcare Corp.

$DHSCHEDULE 13G/ACIK: 0001861795

Subscribe to track DH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Goldman Sachs Amends Stake in Definitive Healthcare (DH) to 5.7%

Company: Definitive Healthcare Corp. (DH) Form: SCHEDULE 13G/A | Filed: 2026-02-09 Significance: High

Filer: GOLDMAN SACHS GROUP INC Relationship: Institutional Filer (Passive)

Holding Details: • Type: Ownership Filing (Amendment) • Security: Class A Common Stock • Shares Owned: 5,935,933 • Ownership %: 5.7% of outstanding shares

Key Insight: Goldman Sachs filed an amendment to its passive stake in Definitive Healthcare, reporting beneficial ownership of 5.7%. This represents a significant institutional position in the small-cap healthcare data company.

Market Context: A holding of this size by a major financial institution like Goldman Sachs is a notable vote of confidence in a company with a market cap of $280 million. The stake is passive, indicating no intent to influence company control.

Comprehensive Analysis

SEC Filing Analysis: Definitive Healthcare Corp. (DH)

Executive Summary

  • Trading Significance: High
  • Key Takeaway: Goldman Sachs Group has filed an amended Schedule 13G, reporting a significant passive beneficial ownership of 5,935,933 shares, representing 5.7% of Definitive Healthcare Corp.'s Class A Common Stock.
  • Market Impact: This filing reaffirms a substantial institutional position in a small-cap company, which can be viewed as a positive signal by the market, though the passive nature of the stake suggests no activist intent.

Company Information

FieldValue
CompanyDefinitive Healthcare Corp.
Ticker SymbolDH
CIK0001861795
IndustryServices-Prepackaged Software

Filer Information

FieldValue
NameGOLDMAN SACHS GROUP INC
CIK0000886982
Title/PositionNot Applicable
RelationshipInstitutional Filer (Holding Company)

Holding Details

FieldValue
Form TypeSCHEDULE 13G/A
Event Date2025-12-31
Transaction CodeNot Applicable
Security TypeClass A Common Stock, par value $0.001 per share
Shares Beneficially Owned5,935,933
Price Per ShareNot Applicable
Total ValueNot Applicable
Ownership TypeIndirect (Shared voting and dispositive power)

Financial Impact Assessment

Holding Materiality

MetricValue
Shares Held5,935,933
% of Shares Outstanding5.75%
Implied Holding Value~$16.1 million (based on current market data)
% of Market Cap5.75%
Materiality AssessmentHighly Significant

Impact Evaluation

  • Market Cap Context: Definitive Healthcare is a small-cap company with a market capitalization of approximately $280 million. A 5.75% stake held by a single institutional entity is a very substantial position and represents a significant portion of the company's public float.
  • Ownership Concentration: This holding demonstrates a notable concentration of ownership. While passive, the position gives Goldman Sachs significant influence over shareholder votes and makes it one of the largest single shareholders.
  • Transaction Significance: As a Schedule 13G filing, this is a statement of ownership, not a single transaction. The significance lies in the size of the stake itself, which surpasses the 5% regulatory reporting threshold. The fact that a premier financial institution maintains such a large position is a material piece of information for the market.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral to Positive
  • Reasoning: The reaffirmation of a large, passive stake by a sophisticated investor like Goldman Sachs can be interpreted as a vote of confidence in the company's long-term prospects. However, as it is an amended filing for a passive stake, it is unlikely to cause immediate, dramatic price movement.

Volume & Sentiment

  • Expected Volume Impact: Low to moderate. The filing itself may not trigger high volume, but it reinforces institutional interest in the stock, which could support liquidity.
  • Sentiment Indicator: Neutral to Bullish. The market generally views large institutional ownership positively, as it suggests due diligence and conviction. The passive nature tempers any strong bullish sentiment related to activism.

Investment Insights

Positive Market Indicators

  • Institutional Validation: A 5.75% stake held by Goldman Sachs provides strong validation for a small-cap company.
  • Significant Ownership: The size of the holding indicates a high-conviction position.

Risk Factors

  • Liquidity Overhang: Should Goldman Sachs decide to liquidate its position, selling nearly 6 million shares could exert significant downward pressure on the stock price, given the company's small market cap.
  • Passive Stance: As a passive investor, Goldman Sachs is not expected to agitate for changes that could unlock shareholder value in the short term.

Key Takeaways

  1. Major Institutional Stake: Goldman Sachs is a major shareholder in Definitive Healthcare with a 5.75% beneficial ownership.
  2. Passive Investment: The stake is held for investment purposes without the intent of influencing control of the company, as certified in the filing.
  3. High Significance for Small-Cap: For a $280 million market cap company, this is a highly material holding that is important for investors to monitor.

Additional Context

Transaction Notes

  • Filing Type: This is a Schedule 13G/A, an amendment to a previous filing, indicating an update to an existing position. The filing was made under Rule 13d-1(b) for passive investors.
  • Ownership Structure: The shares are beneficially owned by The Goldman Sachs Group, Inc. through its subsidiary, Goldman Sachs & Co. LLC.
Topics:#SECFiling#InstitutionalOwnership#GoldmanSachs#DH#DefinitiveHealthcare#Schedule13G#StockMarket#Investing#Finance#SmallCap

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.